Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Janice K P Lam"'
Autor:
Nicole Caduff, Donal McHugh, Anita Murer, Patrick Rämer, Ana Raykova, Vanessa Landtwing, Lisa Rieble, Christian W Keller, Michael Prummer, Laurent Hoffmann, Janice K P Lam, Alan K S Chiang, Friedrich Raulf, Tarik Azzi, Christoph Berger, Tina Rubic-Schneider, Elisabetta Traggiai, Jan D Lünemann, Michael Kammüller, Christian Münz
Publikováno v:
PLoS Pathogens, Vol 16, Iss 12, p e1009167 (2020)
[This corrects the article DOI: 10.1371/journal.ppat.1008477.].
Externí odkaz:
https://doaj.org/article/7480abfa63454e9886f417ae25b9296e
Autor:
Nicole Caduff, Donal McHugh, Anita Murer, Patrick Rämer, Ana Raykova, Vanessa Landtwing, Lisa Rieble, Christian W Keller, Michael Prummer, Laurent Hoffmann, Janice K P Lam, Alan K S Chiang, Friedrich Raulf, Tarik Azzi, Christoph Berger, Tina Rubic-Schneider, Elisabetta Traggiai, Jan D Lünemann, Michael Kammüller, Christian Münz
Publikováno v:
PLoS Pathogens, Vol 16, Iss 4, p e1008477 (2020)
Post-transplant lymphoproliferative disorder (PTLD) is a potentially fatal complication after organ transplantation frequently associated with the Epstein-Barr virus (EBV). Immunosuppressive treatment is thought to allow the expansion of EBV-infected
Externí odkaz:
https://doaj.org/article/55db67c834fb4be880dfce9d23856635
Autor:
Janice K. P. Lam, Tarik Azzi, K. F. Hui, Aikha M. G. Wong, Donal McHugh, Nicole Caduff, K. H. Chan, Christian Münz, Alan K. S. Chiang
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Post-transplant lymphoproliferative disorder (PTLD) is a rare but potentially life-threatening complication, frequently associated with Epstein-Barr virus (EBV), which develops after solid organ or stem cell transplantation. Immunosuppression receive
Externí odkaz:
https://doaj.org/article/c80e669ca5284c7ca91c1f12a1eb2608
Publikováno v:
Frontiers in Microbiology, Vol 9 (2018)
Long term carriers were shown to generate robust polyfunctional T cell (PFC) responses against lytic and latent antigens of Epstein-Barr virus (EBV). However, the time of emergence of PFC responses against EBV antigens, pattern of immunodominance and
Externí odkaz:
https://doaj.org/article/2fc08455f3d245e4aa5411130420880b
Autor:
Koon-Ho Chan, Kwai Fung Hui, Tarik Azzi, Janice K. P. Lam, Donal McHugh, Alan K. S. Chiang, Christian Münz, Nicole Caduff, Aikha M. G. Wong
Publikováno v:
Frontiers in Immunology
Frontiers in Immunology, Vol 11 (2020)
Frontiers in Immunology, Vol 11 (2020)
Post-transplant lymphoproliferative disorder (PTLD) is a rare but potentially life-threatening complication, frequently associated with Epstein-Barr virus (EBV), which develops after solid organ or stem cell transplantation. Immunosuppression receive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::124cd4db21128206ec6956e5f0326af3
https://www.zora.uzh.ch/id/eprint/198962/
https://www.zora.uzh.ch/id/eprint/198962/
Autor:
Tina Rubic-Schneider, Tarik Azzi, Christoph Berger, Elisabetta Traggiai, Michael Prummer, Lisa Rieble, Friedrich Raulf, Nicole Caduff, Vanessa Landtwing, Donal McHugh, Ana Raykova, Michael Kammüller, Christian Münz, Janice K. P. Lam, Jan D. Lünemann, Christian W. Keller, Patrick C. Rämer, Laurent Hoffmann, Anita Murer, Alan K. S. Chiang
Publikováno v:
PLoS Pathogens, Vol 16, Iss 4, p e1008477 (2020)
PLoS Pathogens
PLoS Pathogens, 16 (4)
PLoS Pathogens
PLoS Pathogens, 16 (4)
Post-transplant lymphoproliferative disorder (PTLD) is a potentially fatal complication after organ transplantation frequently associated with the Epstein-Barr virus (EBV). Immunosuppressive treatment is thought to allow the expansion of EBV-infected
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96df845b989374b2afffdde66deca89e
https://doi.org/10.1371/journal.ppat.1008477
https://doi.org/10.1371/journal.ppat.1008477
Autor:
X. Q. Xu, Janice K. P. Lam, Kwok-Hung Chan, Raymond J. Ning, Kwai Fung Hui, Alan K. S. Chiang
Publikováno v:
Frontiers in Microbiology, Vol 9 (2018)
Frontiers in Microbiology
Frontiers in Microbiology
Long term carriers were shown to generate robust polyfunctional T cell (PFC) responses against lytic and latent antigens of Epstein-Barr virus (EBV). However, the time of emergence of PFC responses against EBV antigens, pattern of immunodominance and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be1274b845cf49906b19042c3213d344
https://doi.org/10.3389/fmicb.2018.00416
https://doi.org/10.3389/fmicb.2018.00416